Skip to main content

Lamotrigine

NDC 65841-683 · Zydus Lifesciences Limited

Generic nameLamotrigine
Dosage formTABLET
RouteORAL
Active ingredient(s)LAMOTRIGINE
Strength50 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

65841-683-01 — 100 TABLET in 1 BOTTLE (65841-683-01)

65841-683-05 — 500 TABLET in 1 BOTTLE (65841-683-05)

65841-683-10 — 1000 TABLET in 1 BOTTLE (65841-683-10)

65841-683-16 — 90 TABLET in 1 BOTTLE (65841-683-16)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-773 — Lamotrigine, 63187-487 — Lamotrigine, 63629-4697 — Lamotrigine, 65162-949 — Lamotrigine, 65162-956 — Lamotrigine, 65162-958 — Lamotrigine, 65162-986 — Lamotrigine, 65162-988 — Lamotrigine, 65162-990 — Lamotrigine, 65841-682 — Lamotrigine, 65841-684 — Lamotrigine, 65841-685 — Lamotrigine, 65841-686 — Lamotrigine, 65841-687 — Lamotrigine, 65841-689 — Lamotrigine, 65841-690 — Lamotrigine, 65862-227 — Lamotrigine, 65862-228 — Lamotrigine, 65862-229 — Lamotrigine, 65862-230 — Lamotrigine, +270 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels